APC Anti-Human CD274/PD-L1 Antibody[29E.2A3]

Introducing the APC Anti-Human CD274/PD-L1 Antibody [29E.2A3], a cutting-edge product designed to revolutionize the field of immunology. This antibody, available in a convenient size of 200 tests, is meticulously crafted to provide researchers with unparalleled accuracy and reliability in their investigations.

The APC Anti-Human CD274/PD-L1 Antibody [29E.2A3] boasts an exceptional level of specificity, enabling precise detection and analysis of CD274/PD-L1 expression in human samples. Its advanced formulation ensures minimal background noise, allowing for clear and unambiguous results. With this antibody, researchers can confidently delve into the intricate mechanisms of immune regulation and gain valuable insights into the role of CD274/PD-L1 in various physiological and pathological processes.

Crafted with utmost precision and rigorously validated, this antibody guarantees consistent performance across a wide range of applications, including flow cytometry and immunohistochemistry. Its exceptional sensitivity and robustness make it an indispensable tool for both basic research and clinical studies, facilitating the exploration of novel therapeutic strategies targeting CD274/PD-L1.

The APC Anti-Human CD274/PD-L1 Antibody [29E.2A3] is meticulously manufactured using state-of-the-art techniques and undergoes rigorous quality control measures to ensure utmost reliability and reproducibility. Its exceptional stability and long shelf life make it an ideal choice for laboratories seeking a dependable and cost-effective solution for their research needs.

In summary, the APC Anti-Human CD274/PD-L1 Antibody [29E.2A3] is a game-changing product that empowers researchers to unravel the complexities of immune regulation. With its exceptional specificity, sensitivity, and reliability, this antibody is poised to revolutionize the field of immunology and pave the way for groundbreaking discoveries.